Jerusalem: On Dec 29, Israel’s Oramed Pharmaceuticals announced that its Oravax Medical unit had signed a deal with Vietnam’s Tan Thanh Holdings for the pre-order of 10 million doses of its oral COVID-19. The said COVID-19 vaccine is in clinical trials. Nadav Kidron, chief executive of Oramed, said its oral COVID vaccine was undergoing Phase I clinical trials, and results should be available in early 2022.
